Preventive treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Evaluation of bone histomorphometry in osteoporotics and age matched controls.
作者信息
Lindholm T S, Nilsson O S, Widhe T, Elmsted E, Eriksson S
出版信息
Acta Vitaminol Enzymol. 1982;4(1-2):179-84.
PMID:7124565
Abstract
摘要
相似文献
1
Preventive treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Evaluation of bone histomorphometry in osteoporotics and age matched controls.
Acta Vitaminol Enzymol. 1982;4(1-2):179-84.
2
Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Acta Vitaminol Enzymol. 1981;3(3):170-6.
3
Results of long-term treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.1α-羟基维生素D3与钙剂长期治疗骨质疏松症的结果
Ital J Orthop Traumatol. 1984 Jun;10(2):187-201.
4
Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study.癸酸诺龙、1α-羟基维生素D3或间歇性钙剂输注疗法对症状性骨质疏松症患者骨矿物质含量、骨重塑及骨折率的长期影响：一项双盲对照研究
Bone Miner. 1986 Sep;1(4):347-57.
5
Bone mineral and calcium metabolism before, during and after treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.1α-羟基维生素D3与钙剂治疗骨质疏松症前后及治疗期间的骨矿物质与钙代谢
Scand J Rheumatol. 1982;11(1):55-7. doi: 10.3109/03009748209098116.
6
[The efficacy of combined use of 1 alpha-hydroxyvitamin D3 with calcium supplements in the treatment of osteoporosis].
Nihon Seikeigeka Gakkai Zasshi. 1988 Aug;62(8):723-32.
7
Interim report on treatment of osteoporotic patients with 1 alpha-hydroxyvitamin D3 and calcium.
Clin Orthop Relat Res. 1978 Sep(135):232-40.
8
Treatment of patients with senile, post-menopausal and corticosteroid-induced osteoporosis with 1alpha-hydroxyvitamin D3 and calcium: short- and long-term effects.
Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:183s-189s. doi: 10.1111/j.1365-2265.1977.tb03380.x.
9
Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
Maturitas. 1986 Dec;8(4):281-9. doi: 10.1016/0378-5122(86)90036-8.
10
Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
Clin Orthop Relat Res. 1978 Sep(135):226-31.
Zotero 插件